Bristol Myers Squibb And The New Wave Of Cancer Drugs
By Peter Geschek: Even with the best cancer drugs, doctors are forced to switch from one therapy to the next as the tumors rapidly develop ...
3 Favored Topics
Genetics, human genome, Human Genome Sciences Inc
1 Preferred source
GenomeWeb Daily News
Bristol-Myers Is Fined For Monkey Deaths, But Will $2,600 Matter?
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare ...
Topics:
Bristol Myers Squibb Co
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Filed under: Investing RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market NOKOMIS, Fla.--(BUSINESS WIRE)-- As part of ...
Topics:
Bristol Myers Squibb Co
Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy
By Investment Directions: We had great news today (Thursday), but the response was tepid. Rather than being disappointed or dismissing the news, here ...
Topics:
Bristol Myers Squibb Co
Goodies without wheat
For Marilyn Besner, owner of the new gluten-free WildFlour Bakery and Café in Lawrenceville, both cooking and entrepreneurship began as family ...
Topics:
Bristol Myers Squibb Co
Johnson & Johnson's Short-Term Pipeline
ByJean-Christophe Larsimont: What remains in the pipeline of the eighth largest pharmaceuticals company after the recent approval of its last ...
Topics:
Bristol Myers Squibb Co
Bristol-Myers Squibb experimental melanoma drugs show early success
Tumors shrank in 40 percent of patients, and in 53 percent of those who got the most effective dose combination
Topics:
Bristol Myers Squibb Co
Byetta may ease Parkinson's, study says
Parkinson's symptoms improved in those given Byetta for 12 months, a study said.
Topics:
Bristol Myers Squibb Co
Why Bristol-Myers Is Soaring
The speculation centers around Bristol-Myers' cancer trial results.
Topics:
Bristol Myers Squibb Co
Busy Day For Bristol-Myers Options As Shares Sprint Higher
By Interactive Brokers: BMY - Bristol-Myers Squibb Co. - Shares in drug maker, Bristol-Myers Squibb Co., are ripping higher today, up 6.5% at $44.94, ...
Topics:
Bristol Myers Squibb Co